Pentobarbital Sodium Injection, Solution
Product Images NDC 25021-676

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pentobarbital Sodium (NDC 25021-676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pen03 0000 01)

Chemical structure diagram of pentobarbital sodium, illustrating its molecular framework with labeled functional groups and atoms consistent with the pentobarbital sodium compound.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Pen03 0000 02)

Label for Pentobarbital Sodium Injection, USP 50 mg/mL solution in a 20 mL multi-dose vial by Sagent Pharmaceuticals. The label states the total strength as 1,000 mg per 20 mL for intravenous or intramuscular use, with a caution that it is not suitable for subcutaneous administration. It includes storage and dosage instructions, preservative and ingredients information, and handling precautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.